Staphylococcus aureus Cap5O has UDP-ManNAc dehydrogenase activity and is essential for capsule expression.
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsStructure Analysis of the Staphylococcus aureus UDP- N -acetyl-mannosamine Dehydrogenase Cap5O Involved in Capsular Polysaccharide BiosynthesisBiochemical characterization of WbpA, a UDP-N-acetyl-D-glucosamine 6-dehydrogenase involved in O-antigen biosynthesis in Pseudomonas aeruginosa PAO1Identification and biochemical characterization of two novel UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronic acid 2-epimerases from respiratory pathogensWall teichoic acids mediate increased virulence in Staphylococcus aureus.Capsule production and growth phase influence binding of complement to Staphylococcus aureusThe zwitterionic cell wall teichoic acid of Staphylococcus aureus provokes skin abscesses in mice by a novel CD4+ T-cell-dependent mechanism.Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.Proteins encoded by Sphingomonas elodea ATCC 31461 rmlA and ugpG genes, involved in gellan gum biosynthesis, exhibit both dTDP- and UDP-glucose pyrophosphorylase activities.Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides.The capsular polysaccharide of Staphylococcus aureus is attached to peptidoglycan by the LytR-CpsA-Psr (LCP) family of enzymesStaphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance.Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolatesComplement activation influences Staphylococcus aureus adherence to endothelial cellsCD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infectionsStaphylococcus aureus capsular polysaccharides.sigmaB and the sigmaB-dependent arlRS and yabJ-spoVG loci affect capsule formation in Staphylococcus aureusSurface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.Characterizing non-hydrolyzing Neisseria meningitidis serogroup A UDP-N-acetylglucosamine (UDP-GlcNAc) 2-epimerase using UDP-N-acetylmannosamine (UDP-ManNAc) and derivativesPreclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis.Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.Murine Models of Bacteremia and Surgical Wound Infection for the Evaluation of Staphylococcus aureus Vaccine Candidates.NMR Binding and Functional Assays for Detecting Inhibitors of S. aureus MnaA.Phenotypic heterogeneity and temporal expression of the capsular polysaccharide in Staphylococcus aureus.Three highly conserved proteins catalyze the conversion of UDP-N-acetyl-D-glucosamine to precursors for the biosynthesis of O antigen in Pseudomonas aeruginosa O11 and capsule in Staphylococcus aureus type 5. Implications for the UDP-N-acetyl-L-fucoEfficient one-pot multienzyme synthesis of UDP-sugars using a promiscuous UDP-sugar pyrophosphorylase from Bifidobacterium longum (BLUSP).UDP-Acetyl-Mannosamine Dehydrogenase Is an Endogenous Protein Substrate of Staphylococcus aureus Protein-Tyrosine Kinase ActivityIdentifying genetic diversity of O antigens in Aeromonas hydrophila for molecular serotype detection
P2860
Q24646677-926600C8-E15A-4D22-A007-E622C76F95DBQ27667366-05D2DF8A-5343-46AD-B589-6C89524D84FBQ28492510-51343537-7D6B-4158-A55E-FBC3A2ACFC6EQ28493126-F3E83519-4D9B-4BA3-A858-8F02E62C9055Q30397807-B6532110-0D8F-4827-96AC-A0DE0138FF40Q33552644-862E9E3C-85F3-4DA6-AA6A-C1865CD1EF35Q33719517-3CB223AE-214C-4FB4-9FC1-AB23C031ADA7Q33788238-80AAE786-D9EE-47B9-A6B5-2DC63867D25AQ33913317-57BE0918-D201-4776-9C78-CF63489AEF4DQ33931083-23C52CF1-4B41-4872-A7AB-1FD19313D7D8Q34076020-1AB7543A-11CA-44E2-A6FE-A78C4D0FFD68Q34510564-59ABB3EA-BCD2-4021-8E0C-0E32A5F1A800Q34514398-27354ACB-D0AE-4365-9C9D-698AB10BB65BQ34581644-22F61D9B-4B18-4EF4-B450-78DF83057D98Q34595644-BFCCA495-CEFF-42E0-B922-3A94CADA9387Q34714048-0CB12BC7-1986-4491-A5CC-11601EC8DBFBQ34772232-DE4F2CAD-400B-4F9D-8633-40B7B2970A9AQ35630504-DD7DC471-52EA-4616-8C9D-E33CB402405AQ35947273-EB44A63B-0556-4647-AD7F-36187F6A8237Q36138021-A028ADD7-36E8-4CB0-A0CD-87C24F182ADEQ36421826-B502A22C-EF0A-464D-9A31-CF48842DED1EQ36548288-DB711306-5E30-4287-9D39-2FDFB3AADE61Q39185482-05C5F4BC-F2E6-479A-9921-6D3BB503AA5EQ39896801-1EE8DD85-E07F-473B-8E58-3850F4361074Q40245675-554ECC16-2966-411F-8B7F-BAB495E50231Q40715733-696A4D1D-029E-4381-9FA3-B1BAE041BC24Q40735728-553DAE69-8AE9-45E4-89EC-D76779FAADDBQ41035553-3B81EC72-61C4-41A0-BF75-B99F01D2FBF8Q44237678-03F28393-9ED5-4570-9174-53D282A5055DQ54531933-E7B121FA-2D92-423A-9139-C72F53C42D05Q57776633-A9D3B825-2EE9-4EC6-ADDA-F975333A625AQ58763623-C6474EA0-9864-47AC-8124-752CFB590242
P2860
Staphylococcus aureus Cap5O has UDP-ManNAc dehydrogenase activity and is essential for capsule expression.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@ast
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@en
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@nl
type
label
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@ast
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@en
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@nl
prefLabel
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@ast
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@en
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@nl
P2093
P2860
P1476
Staphylococcus aureus Cap5O ha ...... ential for capsule expression.
@en
P2093
P2860
P304
P356
10.1128/IAI.69.2.917-923.2001
P407
P577
2001-02-01T00:00:00Z